Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Additional Firms Recall Losartan
04/18/2019
A prescription drug used to treat patients with high blood pressure, reduce stroke risk in patients with high blood pressure and an enlarged heart, and treat kidney disease in patients with diabetes is being recalled.
A prescription drug used to treat patients with high blood pressure, reduce stroke risk in patients with high blood pressure and an enlarged heart, and treat kidney disease in patients with diabetes is being recalled.
A prescription drug used to...
04/18/2019
Pharmacy Learning Network

Advertisement

News
FDA Issues Recall for Clonidine Hydrochloride Injection
04/18/2019
A Class III recall is active for a prescription analgesic used in combination with opiates to treat cancer pain that is severe.
A Class III recall is active for a prescription analgesic used in combination with opiates to treat cancer pain that is severe.
A Class III recall is active for...
04/18/2019
Pharmacy Learning Network
News
Two Firms Recall Telmisartan, Amlodipine Tablets
04/18/2019
A recall is active for a prescription drug used to treat high blood pressure.
A recall is active for a prescription drug used to treat high blood pressure.
A recall is active for a...
04/18/2019
Pharmacy Learning Network
News
FDA Recalls Pravastatin Sodium Tablets
04/18/2019
A Class II recall is active for a prescription medication used to treat patients with high cholesterol and triglyceride levels.
A Class II recall is active for a prescription medication used to treat patients with high cholesterol and triglyceride levels.
A Class II recall is active for...
04/18/2019
Pharmacy Learning Network

Advertisement

News
Suboptimal Statin Response Linked to Worse Cardiovascular Disease Risk
04/15/2019
The risk of cardiovascular disease is increased in patients who have a suboptimal LDL cholesterol response to statin therapy, researchers report.
The risk of cardiovascular disease is increased in patients who have a suboptimal LDL cholesterol response to statin therapy, researchers report.
The risk of cardiovascular...
04/15/2019
Pharmacy Learning Network
News
Measles Cases in U.S. Surge Nearly 20% in Early April, CDC Says
04/15/2019
According to federal officials, the number of confirmed cases of measles in the United States this year jumped by nearly 20% in early April.
According to federal officials, the number of confirmed cases of measles in the United States this year jumped by nearly 20% in early April.
According to federal officials,...
04/15/2019
Pharmacy Learning Network
News
Metformin Use Linked to Worse Cognition, B-Vitamin Deficiency
04/12/2019
"This is the first study to assess the impact of hyperglycemia and metformin on the biomarker status of all relevant B-vitamins within one-carbon metabolism and to investigate associations with cognitive health," study authors said.
"This is the first study to assess the impact of hyperglycemia and metformin on the biomarker status of all relevant B-vitamins within one-carbon metabolism and to investigate associations with cognitive health," study authors said.
"This is the first study to...
04/12/2019
Pharmacy Learning Network

Advertisement

News
Multiple Lots of Clindamycin Recalled
04/11/2019
The FDA has issued a Class III recall for a prescription antibiotic used to treat bacterial infections.
The FDA has issued a Class III recall for a prescription antibiotic used to treat bacterial infections.
The FDA has issued a Class III...
04/11/2019
Pharmacy Learning Network
News
FDA Recalls Nystatin Oral Suspension
04/11/2019
A recall is active for nearly 3000 bottles of a prescription treatment used for fungal infections of the mouth.
A recall is active for nearly 3000 bottles of a prescription treatment used for fungal infections of the mouth.
A recall is active for nearly...
04/11/2019
Pharmacy Learning Network
News
Class II Recall Active for Pantoprazole
04/11/2019
The FDA is recalling a prescription proton-pump inhibitor used to treat gastroesophageal reflux disease, a damaged esophagus, or high levels of stomach acid caused by tumors.
The FDA is recalling a prescription proton-pump inhibitor used to treat gastroesophageal reflux disease, a damaged esophagus, or high levels of stomach acid caused by tumors.
The FDA is recalling a...
04/11/2019
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use